Chaetomium retinitis

Retinal Cases and Brief Reports

Volumn 4, Issue 1, 2010, Pages 8-10

  Tabbara, Khalid F ^a,b,c   Wedin, Keith ^a   Al Haddab, Saad ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b The Eye Foundation for Research in Ophthalmology   (Saudi Arabia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; Chaetomium atrobrunneum; CMV retinitis; Fungal retinitis; Immunocompromised host; Optic nerve head; Retina; Retinitis; Uveitis; Vitreous aspirate

Indexed keywords

EID: 80052206106     PISSN: 19351089     EISSN: 19371578     Source Type: Journal    
DOI: 10.1097/ICB.0b013e31819b19b3     Document Type: Article

References (6)

1. Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen-Chaetomium atrobrunneum: case report. Neurosurgery 1998;43:1463-1469. (Pubitemid 28545879)
2. Barron MA, Sutton DA, Veve R, et al. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol 2003;41:5302-5307. (Pubitemid 37429966)
3. Thomas C, Mileusnic D, Carey RB, et al. Fatal Chaetomium cerebritis in a bone marrow transplant patient. Hum Pathol 1999;30:874-879. (Pubitemid 29325798)
4. Parameswaran GI, Segal BH, Almyroudis NG. Antifungal agents in hematopoietic stem cell transplantation. Curr Pharm Des 2008;14:2011-2021.
5. Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol 2008;46:293-302. (Pubitemid 351552484)
6. Serena C, Ortoneda M, Capilla J, et al. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother 2003; 47:3161-3164. (Pubitemid 37229573)